NCT03994627

Brief Summary

The purpose of this study is to continue to provide olaratumab to eligible patients who are currently receiving olaratumab commercially for the treatment of soft tissue sarcoma (STS).

Trial Health

73
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
11 countries

89 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 20, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 21, 2019

Completed
Last Updated

December 16, 2024

Status Verified

December 1, 2024

First QC Date

June 20, 2019

Last Update Submit

December 11, 2024

Conditions

Interventions

Administered intravenously (IV)

Also known as: LY3012207

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Are currently receiving olaratumab and who, in consultation with their treating physician, want to continue their course of therapy.
  • Have metastatic or locally advanced unresectable soft tissue sarcoma not amenable to curative treatment with surgery or radiotherapy.
  • Have given written informed consent.
  • Have an absolute neutrophil count (ANC) ≥1,000/microliter.
  • Females of childbearing potential and males must agree to use highly effective contraceptive precautions during treatment with olaratumab and up to 3 months following the last dose of olaratumab. A highly effective method of birth control is defined as one that results in a low failure rate (that is, \<1% per year) when used consistently and correctly, such as implants, injectables, combined oral contraceptives, some intrauterine contraceptive devices (IUDs), sexual abstinence, or a vasectomized partner.

You may not qualify if:

  • Breastfeeding (patients who discontinue breastfeeding would be considered eligible).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (89)

Ironwood Cancer & Research Centers

Glendale, Arizona, 85306, United States

Location

Marin Specialty Care, Inc

Greenbrae, California, 94904, United States

Location

The Angeles Clinic & Research Institute

Los Angeles, California, 90025, United States

Location

Kaiser Permanente Los Angeles Medical Center

Los Angeles, California, 90027, United States

Location

Kaiser Permanente West Los Angeles

Los Angeles, California, 90034, United States

Location

Kaiser Permanente Moreno Valley

Moreno Valley, California, 92555, United States

Location

University of Colorado Health Hospital

Aurora, Colorado, 80045, United States

Location

UCHealth Cancer Center

Fort Collins, Colorado, 80528, United States

Location

Baptist MD Anderson Cancer Center

Jacksonville, Florida, 32207, United States

Location

Mayo Clinic in Florida

Jacksonville, Florida, 32224, United States

Location

Ocala Oncology, P.A.

Ocala, Florida, 34474, United States

Location

Florida Cancer Specialists

Orlando, Florida, 32804, United States

Location

Orlando Health UF Health Cancer Center

Orlando, Florida, 32806, United States

Location

Florida Cancer Specialists

Sarasota, Florida, 34236, United States

Location

Oncology-Hematology Associates of West Broward

Tamarac, Florida, 33321, United States

Location

Northside Hospital

Athens, Georgia, 30606, United States

Location

Tift Regional Health System Anita Stewart Oncology Center

Tifton, Georgia, 31794, United States

Location

Beacon Cancer Care

Coeur d'Alene, Idaho, 83814, United States

Location

Rush University Medical Center

Chicago, Illinois, 60612, United States

Location

Illinois Cancer Care

Peoria, Illinois, 61615, United States

Location

Hematology Oncology Clinic

Baton Rouge, Louisiana, 70809, United States

Location

Alton Ochsner Medical Center

New Orleans, Louisiana, 70121, United States

Location

University of Maryland, Baltimore

Baltimore, Maryland, 21201, United States

Location

SKCCC at Johns Hopkins

Baltimore, Maryland, 21287, United States

Location

Baltimore Washington Health Services

Glen Burnie, Maryland, 21061, United States

Location

University of Massachusetts Medical Center

Worcester, Massachusetts, 01655, United States

Location

Henry Ford Macomb Hospital

Clinton Township, Michigan, 48038, United States

Location

Cancer & Hematology Centers of Western Michigan

Grand Rapids, Michigan, 49503, United States

Location

St. Luke's Hospital of Duluth

Duluth, Minnesota, 55805, United States

Location

Masonic Cancer Center, University

Minneapolis, Minnesota, 55455, United States

Location

Jackson Oncology Associates, PLLC

Jackson, Mississippi, 39202, United States

Location

University of Mississippi School of Medicine

Jackson, Mississippi, 39216, United States

Location

County Oncologist, Inc.

St Louis, Missouri, 63136, United States

Location

Cooper Hospital University Medical Center

Camden, New Jersey, 08103, United States

Location

Regional Cancer Care Associates, LLC

East Brunswick, New Jersey, 08816, United States

Location

Hudson Valley Cancer Center

Fishkill, New York, 12524, United States

Location

SUNY Upstate Medical University

Syracuse, New York, 13210, United States

Location

East Carolina School of Medicine

Greenville, North Carolina, 27834, United States

Location

Aultman Medical Group Hematology & Oncology

Canton, Ohio, 44710, United States

Location

University of Cincinnati Cancer Institute

Cincinnati, Ohio, 45219, United States

Location

Cleveland Clinic Foundation

Cleveland, Ohio, 44195, United States

Location

The James Cancer Hospital

Columbus, Ohio, 43210, United States

Location

UPMC Hillman Cancer Center

Greenville, Pennsylvania, 16125, United States

Location

Steward Sharon Regional Cancer Center

Hermitage, Pennsylvania, 16148, United States

Location

UPMC Hillman Cancer Center

New Castle, Pennsylvania, 16105, United States

Location

Abramson Cancer Center at Pennsylvania Hospital

Philadelphia, Pennsylvania, 19106, United States

Location

The West Clinic

Germantown, Tennessee, 38138, United States

Location

Tennessee Oncology PLLC

Hixson, Tennessee, 37343, United States

Location

UVAHS Emily Couric Clin Cancer Ctr

Charlottesville, Virginia, 22903, United States

Location

Kaiser Permanente of WA

Olympia, Washington, 98506, United States

Location

Harrison HealthPartners Hematology

Poulsbo, Washington, 98370, United States

Location

Seattle Integrative Cancer Center

Renton, Washington, 98360, United States

Location

Mon Health Medical Center

Morgantown, West Virginia, 26505, United States

Location

SSM Health Cancer Care Center

Madison, Wisconsin, 53717, United States

Location

West Allis Memorial Hospital

West Allis, Wisconsin, 53227, United States

Location

Ordensklinikum Linz GmbH Elisabethinen

Linz, Upper Austria, 4020, Austria

Location

Kepler Universitätsklinikum GmbH, Med Campus III

Linz, Upper Austria, 4021, Austria

Location

CLION - Clínica de Oncologia

Salvador, Estado de Bahia, 40170-010, Brazil

Location

Instituto Londrina de Radioterapia

Londrina, Paraná, 86050-435, Brazil

Location

CHUM

Montreal, Quebec, H2V 2E2, Canada

Location

Allan Blair Cancer Centre

Regina, Saskatchewan, S4T 7T1, Canada

Location

Szabolcs-Szatmár-Bereg Megyei Kórházak és Egyetemi Oktatókórház, Jósa András Oktatókórház

Nyíregyháza, Szabolcs-Szatmár-Bereg, 4400, Hungary

Location

National Institute of Oncology

Budapest, 1122, Hungary

Location

Healthcare Global Enterprises Limited (HCG)

Bangalore, Karnataka, 560027, India

Location

Istituto Oncologico Veneto IRCCS

Padua, Veneto, 35128, Italy

Location

IRCCS - AOU di Bologna

Bologna, 40138, Italy

Location

Ospedale Santa Chiara di Trento

Trento, 38122, Italy

Location

Gachon University Gil Medical Center

Namdong-gu, Incheon, 21565, South Korea

Location

Inha University Hospital

Incheon, Incheon-gwangyeoksi [Incheon], 22332, South Korea

Location

Seoul National University Bundang Hospital

Seongnam, Kyǒnggi-do, 13620, South Korea

Location

Pusan National University Hospital

Busan, Pusan-Kwangyǒkshi, 49241, South Korea

Location

Wonkwang University Hospital

Iksan-si, Jeonlabuk-do, 54538, South Korea

Location

Hospital Universitario de Canarias

Santa Cruz de Tenerife, La Laguna, 38320, Spain

Location

Hospital De Navarra

Pamplona, Navarre, 31008, Spain

Location

Clínica Mompia

Cantabria, Santa Cruz de Bezana, 39109, Spain

Location

Hospital Universitari Vall d'Hebron

Barcelona, 08035, Spain

Location

Cl. Universitaria Navarra

Madrid, 28022, Spain

Location

Centro Oncológico MD Anderson

Madrid, 28033, Spain

Location

Hospital Clinico San Carlos

Madrid, 28040, Spain

Location

Hospital Madrid Norte Sanchinarro

Madrid, 28050, Spain

Location

Gerencia de Asistencia Sanitaria de Segovia_Hospital General de Segovia

Segovia, 40002, Spain

Location

Hospital Universitario Virgen Del Rocio

Seville, 41013, Spain

Location

Fundación Instituto Valenciano de Oncología

Valencia, 46009, Spain

Location

Hospital Universitario La Fe de Valencia

Valencia, 46026, Spain

Location

China Medical University Hospital

Taichung, 40447, Taiwan

Location

The Christie NHS Foundation Trust

Manchester, Greater Manchester, M20 4BX, United Kingdom

Location

Ninewells Hospital

Dundee, Scotland, DD1 9SY, United Kingdom

Location

Queen Elizabeth Hospital Birmingham

Birmingham, B15 2WB, United Kingdom

Location

Cambridge University Hospitals NHS Foundation Trust

Cambridge, CB2 0QQ, United Kingdom

Location

MeSH Terms

Conditions

Sarcoma

Interventions

olaratumab

Condition Hierarchy (Ancestors)

Neoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasms

Study Design

Study Type
expanded access
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 20, 2019

First Posted

June 21, 2019

Last Updated

December 16, 2024

Record last verified: 2024-12

Locations